Rare diseases
Investigational molecules
Locations
Back to France961 clinical trials in Nice, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study Comparing Ivonescimab to FOLFOX Drug Combination for Patients with Advanced Biliary Tract Cancer
FranceStudy on Early Treatment of Plaque Psoriasis with Bimekizumab and Clobetasol Propionate for Patients with Chronic Inflammation
FranceStudy on Lithium Carbonate for Patients with TBR1-Related Neurocognitive Disorder
FranceStudy Comparing FOLFOX (Oxaliplatin, Fluorouracil, Calcium Folinate) to Gemcitabine for Patients with Metastatic Pancreatic Cancer Not Suitable for FOLFIRINOX
FranceStudy on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease
FranceStudy on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation
FranceStudy of TP-3654 and Momelotinib for Patients with Intermediate or High-risk Myelofibrosis
FranceStudy on the Physical Impact of Multiple Sclerosis and Continued Access to Ocrelizumab for Patients Previously in a Related Study
FranceStudy on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients
FranceStudy of Ezabenlimab and Drug Combination for Stage III Anal Cancer Treatment
FranceStudy on Post-Operative Chemotherapy with Doxorubicin and Trabectedin for Patients with High-Risk Localized Uterine Leiomyosarcoma
FranceStudy Comparing Elranatamab, Daratumumab, and Lenalidomide with Daratumumab, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on neurodegenerative conditions and movement disorders, including trials evaluating new treatments for Amyotrophic Lateral Sclerosis and Essential Tremor.
Studies aim to improve quality of life and slow disease progression through targeted therapeutic approaches.
Comprehensive research into inflammatory disorders, including studies on Psoriatic Arthritis and innovative treatments for various autoimmune conditions.
Focus on developing targeted therapies and combination treatments for better disease control.
Advanced studies in cancer treatment, particularly focusing on head and neck cancers and innovative approaches in lung cancer therapy.
Investigating combination therapies and targeted treatments for improved patient outcomes.
Groundbreaking research in inflammatory bowel diseases, including novel approaches for Crohn's Disease and Ulcerative Colitis treatment.
Exploring innovative therapeutic strategies and microbiome-based treatments.
Critical research in HIV prevention and treatment, focusing on long-acting preventive medications and innovative therapeutic approaches.
Development of new preventive measures and treatment options for at-risk populations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
